You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SBRT

Showing 1 - 25 of 1,041
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in New Haven (Relugolix 120 MG [Orgovyx], SBRT standard of care radiotherapy treatment)

Not yet recruiting
  • Prostate Cancer
  • Relugolix 120 MG [Orgovyx]
  • SBRT standard of care radiotherapy treatment
  • New Haven, Connecticut
    Yale Cancer Center
Oct 26, 2023

Prostate Adenocarcinoma Trial in Madrid (Prostate SBRT (stereotactic body radiation therapy) with focal boost)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Prostate SBRT (stereotactic body radiation therapy) with focal boost
  • Madrid, Spain
    La Princesa University Hospital, Health Research Institute, Madr
Jun 16, 2023

Locally Advanced Pancreatic Cancer Trial (Stereotactic body radiation(SBRT), Zimberelimab (GLS-010))

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Stereotactic body radiation(SBRT)
  • Zimberelimab (GLS-010)
  • (no location specified)
Aug 22, 2023

Spine Metastases, Radiation Therapy, Pain Trial in Montréal (Vertebroplasty, Stereotactic Body Radiation Therapy only)

Not yet recruiting
  • Spine Metastases
  • +2 more
  • Vertebroplasty
  • Stereotactic Body Radiation Therapy only
  • Montréal, Quebec, Canada
    Véronique Freire
Jan 25, 2023

Stereotactic Body Radiotherapy for Medically Inoperable

Recruiting
  • Kidney Neoplasm
  • +2 more
  • SBRT
  • Terrassa, Barcelona, Spain
    Consorci Sanitari de Terrassa
Apr 5, 2023

NSCLC Metastatic Trial in Stockholm (Stereotactic body radiation therapy (SBRT), Temporary Stopping)

Recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Stereotactic body radiation therapy (SBRT)
  • Temporary Stopping
  • Stockholm, Solna, Sweden
    Karolinska University Hospital
Nov 9, 2023

Localized Prostate Cancer, Low Risk Prostate Cancer, Intermediate Risk Prostate Cancer Trial (3 fractions of prostate SBRT)

Not yet recruiting
  • Localized Prostate Cancer
  • +2 more
  • 3 fractions of prostate SBRT
  • (no location specified)
Oct 31, 2023

Prostate Cancer Trial in Middlesbrough (SBRT)

Recruiting
  • Prostate Cancer
  • SBRT
  • Middlesbrough, South Tees, United Kingdom
    James Cook University Hospital
Nov 10, 2022

Prostate Cancer Trial in Mineola, New York (Two-Fraction Stereotactic Body Radiation Therapy (SBRT))

Not yet recruiting
  • Prostate Cancer
  • Two-Fraction Stereotactic Body Radiation Therapy (SBRT)
  • Mineola, New York
  • +1 more
May 9, 2023

Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Trial (SBRT, Cadonilimab)

Not yet recruiting
  • Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
  • (no location specified)
Feb 8, 2023

Colorectal Cancer Trial (Tislelizumab, Irinotecan Hydrochloride, cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Mar 23, 2023

Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)

Not yet recruiting
  • Prostatic Cancer
  • High Dose Brachytherapy
  • Stereostatic Body Radiation Therapy
  • (no location specified)
Mar 3, 2023

Pancreatic Carcinoma Trial in Nanjing (Toripalimab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Carcinoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Oct 6, 2023

Metastatic Colorectal Cancer Trial in Wuhan (SBRT, Fruquintinib, Cadonilimab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • SBRT, Fruquintinib, Cadonilimab
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Feb 18, 2023

Esophageal Squamous Cell Carcinoma, Oligometastatic Disease Trial in Guangzhou (PD-1 combined with SBRT)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Oligometastatic Disease
  • PD-1 combined with SBRT
  • Guangzhou, Guangdong, China
    Mian Xi
Dec 18, 2022

Unresectable Hepatocellular Carcinoma, Oligometastatic Disease Trial in Beijing (SBRT plus tislelizumab and regorafenib)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Oligometastatic Disease
  • SBRT plus tislelizumab and regorafenib
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jun 15, 2023

Lung Trial in Charlotte (SGRT)

Recruiting
  • Lung
  • SGRT
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 27, 2023

Advanced Nasopharyngeal Carcinoma Trial in Hangzhou (SBRT)

Recruiting
  • Advanced Nasopharyngeal Carcinoma
  • SBRT
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Dec 5, 2022

Bone Metastases Trial in Houston (Radiation Therapy)

Not yet recruiting
  • Bone Metastases
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Sep 26, 2023

SBRT for Oligometastatic Castration-Refractory Prostate Cancer

Completed
  • Prostate Cancer
  • SBRT
  • Rochester, Minnesota
    Mayo Clinic
Aug 23, 2022

NSCLC Trial (Metastatic vertebrae treated with SBRT)

Not yet recruiting
  • NSCLC
  • Metastatic vertebrae treated with SBRT
  • (no location specified)
Oct 8, 2022

NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

Not yet recruiting
  • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
  • tereotactic body radiotherapy
  • (no location specified)
Dec 1, 2023

Non Small Cell Lung Cancer Trial in Ostrava (Chemotherapy, Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT),

Recruiting
  • Non Small Cell Lung Cancer
  • Chemotherapy
  • +2 more
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Dec 19, 2022

Prostate Cancer Trial in Québec (Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant, Stereotactic Body

Recruiting
  • Prostate Cancer
  • Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant
  • Stereotactic Body Radiation Therapy to the prostate
  • Québec, Canada
    Centre Intégré de Cancérologie, CHU de Québec-Université Laval
Sep 21, 2023

Treatment Trial in Shanghai (ADT, SBRT)

Recruiting
  • Treatment
  • Shanghai, Shanghai, China
    Changhai hospital
Aug 9, 2022